Release Date: 31/01/17 20:28 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 83.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%